<< Key trends and events in the biopharma industry | Salix Pharmaceuticals sued over alleged kidney damage due to OsmoPrep >>
Read in | English | Deutsch | Português | 日本語 | 繁體中文 | العربية | Ελληνικά | Bahasa

Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Published on December 24, 2009 at 4:02 AM · No Comments

Smith & Nephew (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announces the agreement to partner with Gunze Limited, Japan and exclusively distribute PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand.

PELNAC is a collagen matrix with silicone top layer for use on full thickness injuries such as burns and trauma. It helps promote the regeneration of damaged dermal layers as an alternative to using the patient's own dermis which may not be available with extensive injuries. PELNAC will be available from Smith and Nephew in Japan from January 1st, 2010, with South Africa and Australia following shortly after.

"I am delighted that we can add PELNAC to our portfolio," said Leon Hoare, President - Advanced Wound Management, Asia Pacific. "It provides a solution to the needs of many plastic and burn surgeons who deal with serious injuries and helps to support the patients with a good cosmetic outcome."

"The addition of PELNAC enhances our wound care offering for burns and trauma injuries," commented Roger Teasdale, President, Smith & Nephew Wound Management. "We are very pleased to be working with Gunze and look forward to the opportunities that lay ahead for both businesses."

SOURCE: Smith & Nephew PLC

Posted in: Pharmaceutical News

Tags: , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading